Four Loeb Partners Recognized in the 2023 LMG Life Sciences Rankings

Loeb & Loeb is pleased to announce that Capital Markets & Corporate partner Norwood Beveridge; Food & Drug Administration partner Jim Czaban; Mitch Nussbaum, vice chair of Loeb & Loeb and co-chair of the firm’s Capital Markets & Corporate department; and Mark Waddell, co-chair of the Life Sciences practice and chair of the Patent Litigation & Counseling practice, were recognized in the 2023 edition of the LMG Life Sciences rankings, a definitive guide to lawyers and law firms that specialize in the life sciences industry.

The rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement. Specifically, Norwood and Mitch were recognized in the Corporate category, while Jim was recognized in the FDA: Medical Device and FDA: Pharmaceutical categories and Mark was recognized in the Patent Strategy & Management category.

LMG Life Sciences is the only legal ranking directory to identify the leading law firms and individuals in each practice area of the life sciences sector through deep analysis of the business and legal developments in the sector. The intricacies of life science products require a diverse array of legal expertise across many disciplines. From regulatory approval or patent filing to collaborative transactions or product liabilities, legal practitioners play an important role in guiding a product through its life cycle.

For more information, please visit LMG Life Sciences’ website.